GSK says U.S. FDA approves Boostrix for immunization during pregnancy
October 10, 2022 at 02:18 AM EDT
The vaccine is also indicated against tetanus, diphtheria and pertussis in individuals aged 10 years and older, GSK said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|